ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 238

Relationship Between Ultrasonographic Synovial Inflammation  and Ultrasonographic Urate Deposition Findings in Patients with Gout

Fernando Perez-Ruiz1,2, Sandra P. Chinchilla-Gallo3, Irati Urionagüena4 and Elena Garmendia3,5, 1Rheumatology Division, Hospital Universitario Cruces, Barakaldo, Spain, 2BioCruces Health Research Institute, Baracaldo, Spain, 3Rheumatology Division, Hospital Universitario Cruces, Baracaldo, Spain, 4Rheumatology Division, Hospital Universitario ruces, Baracaldo, Spain, 5Biocruces Helath Research Institute, Baracaldo, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Deposition, gout, inflammatory arthritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: urate intra-articular deposits are seen in ultrasound as double contour sign (DCS), and hyperechogenic aggregates and tophi, but the extent of contribution of any of these findings to synovial inflammation has yet to be determined. Only tophi have been shown to date sensitivity to change during urate-lowering therapy.

Methods: to evaluate the association between DCS and tophi with the presence of synovial inflammation in ultrasound examination, patients with crystal-proven gout were recruited from two cohorts of prospective follow-up, one on active treatment and the other after withdrawal of urate-lowering therapy, were to be consecutively included. They had to be asymptomatic (no flare, no chronic swelling) for at least 4 years, not on colchicine, NSAID, corticosteroids, or IL-blockers. Ultrasonography of the first metatarsophalangeal joint (1st MTP) and of the non-dominant knee was performed by an skilled explorer who was blinded for clinical data. The DCS was predefined as absent or present and in in less or more than 50% of the synovial surface. In the knee joint, the DCS location was also assessed as present in one or both femoral condyles. The presence of tophi was evaluated as hyperechogenic conglomerates of at least 5mm in maximum diameter, with a hypoechogenic halo associated. Synovial inflammation was evaluated by the measurement of synovial thickening with a semi-quantitative scale (0-3) and Power-Doppler (PD) with a semiquantitative scale (0-3). Bi-variable and multiple regression analysis were performed.

Results: ultrasonopgraphy was proposed to 100 consecutive patients who fulfilled criteria, of which 88 agreed and attended the appointment. All of them were male, with a median age of 57 ± 9 years, 74% with previous involvement of 1st MTP joint and 59% of the examined knee. Thirteen patients were excluded from analysis due to the presence of ultrasonographic chondrocalcinosis in the knee. The frequency of deposits in both cohorts was not different, a pooled analysis therefore being conducted. The descriptive findings are presented in the table:

%

 

Any deposit

DCS

Synovitis>0

Synovitis>1

Tophus

PD>0

PD>1

1st MTP

64.7

54.8

29.8

48.8

9.4

48.8

21.2

 

Knee

52.9

48.2

17.6

53.0

1.2

47.1

25.9

Multiple regression analysis showed that the presence of synovitis >0 was only statistically associated in the 1st MTP to tophi (R2 0.31), and in the knee to the presence of extense or bilateral DCS and tophi (R2 0.28). The PD>0 signal was only associated in both 1st MTP and in knee to tophi (R2 0.25 and 0.18, respectively). The more restrictive analysis of synovitis>1 and PD>1 did not show changes in the results, although numbers were small.

Conclusion: ultrasonographic urate deposits, as tophi or extense double contour) are associated to synovitis or active synovitis (intra-articular synovitis with PD signal) as markers of synovial inflammation. The presence of tophi is the main factor associated, so the resolution of the intra-articular tophi seems to be the principal therapeutic goal for urate-lowering therapy.


Disclosure: F. Perez-Ruiz, AstraZeneca, 5,AstraZeneca, 8,Menarini, 5,Menarini, 8; S. P. Chinchilla-Gallo, None; I. Urionagüena, None; E. Garmendia, None.

To cite this abstract in AMA style:

Perez-Ruiz F, Chinchilla-Gallo SP, Urionagüena I, Garmendia E. Relationship Between Ultrasonographic Synovial Inflammation  and Ultrasonographic Urate Deposition Findings in Patients with Gout [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/relationship-between-ultrasonographic-synovial-inflammation-and-ultrasonographic-urate-deposition-findings-in-patients-with-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-ultrasonographic-synovial-inflammation-and-ultrasonographic-urate-deposition-findings-in-patients-with-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology